Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2

AIDS Research and Human Retroviruses

Volumn 15, Issue 9, 1999, Pages 803-810

  Regamey, Nicolas ^a,b   Harr, Thomas ^a,b   Battegay, Manuel ^a,c   Erb, Peter ^a,b  

^a Basel Center for HIV Research   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; VIRUS RNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FLOW CYTOMETRY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 0032989293     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310700     Document Type: Article

References (38)

1. Klenerman P and Zinkernagel RM: What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? Immunol Rev 1997;159:5-16.
2. Pantaleo G and Fauci AS: Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996;50:825-854.
3. Ameisen JC and Capron A: Cell dysfunction and depletion in AIDS - the programmed cell death hypothesis. Immunol Today 1991;12:102-105.
4. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, and Miedema F: Programmed death of T-cells in HIV-1 infection. Science 1992;257:217-219.
5. Gougeon ML and Montagnier L: Apoptosis in AIDS. Science 1993;260:1269-1270.
6. Ameisen JC, Estaquier J, Idziorek T, and De Bels F: Programmed cell death and AIDS pathogenesis: Significance and potential mechanisms. Curr Top Microbiol Immunol 1995;200:195-211.
7. Rothen M, Gratzl S, Hirsch HH, and Moroni C: Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res Hum Retroviruses 1997;13:771-779.
8. Akbar AN and Salmon M: Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death. Immunol Today 1997;18:72-76.
9. Broome HE, Dargan CM, Krajewski S, and Reed JC: Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 1995;155:2311-2317.
10. + T-cell apoptosis in patients with acute herpesvirus infections: Loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression. Immunology 1996;88: 508-515.
11. Bofill M, Gombert W, Borthwick NJ, Akbar AN, McLaughlin JE, Lee CA, Johnson MA, Pinching AJ, and Janossy G: Presence of CD3(+)CD8(+)Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1(+) patients. Am J Pathol 1995;146:1542-1555.
12. + T lymphocytes during HIV infection. J Immunol 1996;156:2282-2293.
13. Gehri R, Hahn S, Rothen M, Steuerwald M, Nuesch R, and Erb P: The Fas receptor in HIV infection: Expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 1996; 10:9-16.
14. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, and Yagita H: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995;182:1777-1783.
15. Yonehara S, Nishimura Y, Kishil S, Yonehara M, Takazawa K, Tamatani T, and Ishii A: Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. Int Immunol 1994;6:1849-1856.
16. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
17. Vermes I, Haanen C, Steffensnakken H, and Reutelingsperger C: A novel assay for apoptosis - flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39-51.
18. Ledru E, Lecoeur H, Garcia S, Debord T, and Gougeon ML: Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 1998;160: 3194-3206.
19. Schnittman SM, Psallidopoulos MC, Lane HC, Thompson L, Baseler M, Massari F, Fox CH, Salzman NP, and Fauci AS: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 1989;245:305-308.
20. Brinchmann JE, Albert J, and Vartdal F: Few infected CD4+ T-cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type-1 infection. J Virol 1991;65:2019-2023.
21. Patterson BK, Till M, Otto P, Goolsby C, Furtado MR, McBride LJ, and Wolinsky SM: Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993;260:976-979.
22. Holzer TJ, Heynen CA, Novak RM, Pitrak DL, and Dawson GJ: Frequency of cells positive for HIV-1 p24 antigen assessed by flow cytometry. AIDS 1993;7:S3-S5.
23. Oltvai ZN, Milliman CL, and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
24. Hashimoto F, Oyaizu N, Kalyanaraman VS, and Pahwa S: Modulation of Bcl-2 protein by CD4 cross-linking: A possible mechanism for lymphocyte apoptosis in human immunodeficiency virus infection and for rescue of apoptosis by interleukin-2. Blood 1997;90:745-753.
25. Roederer M, Dubs JG, Anderson MT, Raju PA, and Herzenberg LA: CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest 1995;95:2061-2066.
26. Gougeon ML, Lecoeur H, Dulioust A, Enouf MG, Crouvoiser M, Goujard C, Debord T, and Montagnier L: Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996;156:3509-3520.
27. Muro Cacho CA, Pantaleo G, and Fauci AS: Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 1995;154:5555-5566.
28. Johnson N and Parkin JM: Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 1998;113:229-234.
29. Aries SP, Weyrich K, Schaaf B, Hansen F, Dennin RH, and Dalhoff K: Early T-cell apoptosis and Fas expression during anti-retroviral therapy in individuals infected with human immunodeficiency virus-1. Scand J Immunol 1998;48:86-91.
30. Clerici M and Shearer GM: The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-581.
31. Clerici M, Sarin A, Coffman RL, Wynn TA, Blatt SP, Hendrix CW, Wolf SF, Shearer GM, and Henkart PA: Type I/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994;91:11811-11815.
32. Adachi Y, Oyaizu N, Than S, McCloskey TW, and Pahwa S: IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: Correlation with its ability to block culture-induced down-modulation of Bcl-2. J Immunol 1996;157:4184-4193.
33. Debatin KM, Fahrig Faissner A, Enenkel Stoodt S, Kreuz W, Benner A, and Krammer PH: High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 1994;83:3101-3103. [Letter]
34. Katsikis PD, Wunderlich ES, Smith CA, and Herzenberg LA: Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995;181:2029-2036.
35. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, and Paya CV: Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol 1996;70:199-206.
36. Noraz N, Gozlan J, Corbeil J, Brunner T, and Spector SA: HIV-induced apoptosis of activated primary CD4+ T lymphocytes is not mediated by Fas-Fas ligand. AIDS 1997;11: 1671-1680.
37. Sloand EM, Maciejewski JP, Sato T, Bruny J, Kumar P, Kim S, Weichold FF, and Young NS: The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection. J Clin Invest 1998;101:195-201.
38. Gandhi RT, Chen BK, Straus SE, Dale JK, Lenardo MJ, and Baltimore D: HIV-1 directly kills CD4(+) T cells by a Fas-independent mechanism. J Exp Med 1998;187:1113-1122.